Detection and Quantification of Calcitonin Gene-Related Peptide (CGRP) in Human Plasma Using a Modified Enzyme-Linked Immunosorbent Assay

作者： Pavan S. Krishnan1,2, Fernando T. Zamuner1,3, Carolyn M. Jenks1, Johnny Y. Xie4, Lisa Zhang5, Mohammed Lehar1, Neal S. Fedarko6, Mariana Brait1,3, John P. Carey1 1Department of Otolaryngology-Head & Neck Surgery,Johns Hopkins University School of Medicine, 2Virginia Commonwealth University School of Medicine, 3Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center,Johns Hopkins University School of Medicine, 4Department of Otolaryngology-Head and Neck Surgery,University of Michigan Medical School, 5Department of Otolaryngology-Head and Neck Surgery,The Ohio State University College of Medicine, 6ICTR Clinical Research Core Laboratory,Johns Hopkins University School of Medicine

简介：

Overview

This article presents a validated enzyme-linked immunosorbent assay (ELISA) protocol for the purification and quantification of calcitonin gene-related peptide (CGRP) in human plasma. The method addresses inconsistencies in previous CGRP concentration data by standardizing the quantification process.

Key Study Components

Area of Science

• Neuroscience
• Biochemistry
• Clinical Research

Background

• CGRP is implicated in various disease processes, including migraine.
• Previous studies have shown inconsistent CGRP concentration results.
• A standardized methodology is essential for accurate quantification.
• The protocol includes measures to prevent protease degradation.

Purpose of Study

• To develop a validated ELISA protocol for CGRP quantification.
• To standardize methodologies for future research on CGRP.
• To explore CGRP's potential as a biomarker in various diseases.

Methods Used

• Collection of 5 milliliters of whole blood from the antecubital vein.
• Use of a 6 milliliter vacutainer EDTA tube for blood collection.
• Application of solid phase extraction for purification.
• Inclusion of blocking buffer to limit non-specific binding.

Main Results

• The modified ELISA protocol allows for accurate CGRP quantification.
• Validation experiments confirm the reliability of the method.
• The protocol can be applied to standardize future CGRP studies.
• Potential implications for understanding CGRP's role in various diseases.

Conclusions

• The validated ELISA protocol enhances the accuracy of CGRP measurement.
• Standardization of CGRP quantification may improve research outcomes.
• Further studies could explore CGRP as a biomarker for multiple conditions.

Frequently Asked Questions